On 3/18/25, Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) stock enjoyed a major increase of 26.1%, closing at $20.53. However, this advance was accompanied by exceptionally low trading volume at 0% of normal. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 52.4% during the last week.
Current PriceTarget Research Rating
Tonix Pharmaceuticals Holding has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Tonix Pharmaceuticals Holding has a very low Appreciation Score of 4 but a very high Power Rating of 92, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment